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In this issue Diverse Disciplines, one 
Goal: Improving Lives
By Herb Whiteley
The breadth and depth of biomedical discovery at the College of Veteri-
nary Medicine may surprise you.
Our faculty are testing new materials that make bone surgeries safer 
and more effective. They are delving into the causes of periodic die-offs 
of lions in the Serengeti. They are identifying the mechanisms by which 
PCBs damage the nervous system—and reaching out to educate people 
at risk of ingesting harmful levels of PCBs from fish.
Research at our College crosses species, disciplines, and oceans. Our 
faculty are internationally recognized. Some have joint appointments in 
anthropology, bioengineering, psychology, and nutritional sciences, to 
name a few areas. Their work may focus on a single gene or may encom-
pass entire ecosystems.
The common thread uniting these diverse fields of inquiry is their 
potential to make life better. At our College, the quest for new knowl-
edge begins with caring, with asking why and how, and with a belief that 
finding the answers to those questions brings the promise of a better life 
for animals and people.
This special issue of Veterinary Report showcases research initiatives 
throughout our College. I invite you to learn more about what we do. I 
hope you’ll be inspired to participate in our efforts, whether by referring 
cases to a clinical trial, collaborating with one of our faculty, or support-
ing our work through the gift of a chair or fellowship.
I welcome your comments. You can reach me at  
dean@cvm.uiuc.edu. 
Features
Solving a Viral Mystery:  .  .  .  .  .  . 1
White Paper on PRRS 
Vaccine  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  . 2
Asthma Clues   .  .  .  .  .  .  .  .  .  .  .  .  .  .  . 3
Alleviating Bone Cancer  
Pain   .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  . 4
Standards for Canine 
Lymphoma Diagnoses  .  .  .  .  .  .  . 6
Stem Cell Biology  .  .  .  .  .  .  .  .  .  .  .  . 7
Keeping Microbes Out of 
Water Supplies  .  .  .  .  .  .  .  .  .  .  .  .  .  . 8
College News   .  .  .  .  .  .  .  .  .  .  .  .  .  10
Discoveries in the News  .  .  .  .  .12
Research Funding  .  .  .  .  .  .  .  .  .  14
Featured Faculty:  
Tom Graves   .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  15
New Faces   .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  16
Student Research   .  .  .  .  .  .  .  .  .  .17
Current Clinical Trials  .  .  .  .  .  .  18
Advancement News  .  .  .  .  .  .  .  18









and how, and 
with a belief 
that finding 
the answers to 
those questions 
brings the 
promise of a 
better life for 
animals and 
people .”
On the cover: Liz Estoff works 
in the research lab of Dr . Tony 
Goldberg . Photo by Jason 
Lindsey .
Veterinary Report • Fall 2007 q
By Chris Beuoy
In the late 1980s a disease emerged among U.S. swine 
herds that wreaked economic havoc on the pork industry 
by causing abortion and failure to thrive in growing pigs. 
The culprit, known initially as the “mystery swine 
disease,” was eventually named Porcine Reproduction and 
Respiratory Syndrome (PRRS). It is caused by a single-
strand RNA virus that is highly infectious and variable.
Over the past 20 years, the PRRS virus has stymied 
scientists hoping to find a vaccine for what has become the 
most economically important health problem facing pork 
producers, accounting for more than $560 million in losses 
each year. 
A June 1 colloquium organized at the College of Vet-
erinary Medicine (see side bar) assessed the prospects for 
development of an effective PRRS virus vaccine. Experts 
agreed that while modified-live virus vaccines are effec-
tive against reinfection with the same viral strain, the 
large number of variations—PRRS is more variable than 
the AIDS virus—has left pork producers without effec-
tive control strategies. Indeed, it was concluded that basic 
questions about the biology of the virus and how it causes 
disease have gone unanswered.
Two Problems to solve
Dr. Federico Zuckermann, an immunologist in the Depart-
ment of Pathobiology, believes he may be close to finding 
some answers.
“To create an effective vaccine you have to solve two 
problems,” he says. “You have to develop a robust cell line in 
which to grow the virus and you have to isolate a strain of 
the virus that will stimulate immunity to many variants.” 
His laboratory has been successful on both counts. 
Until now, the only available cell line that supports 
growth of the PRRS virus comes from a simian kidney cell 
line. Because of patent restrictions, one company controls 
the commercial use of this cell line, which has stifled the 
development of an effective vaccine against this virus. This 
imposed limitation has led many researchers to attempt to 
develop alternative cell lines—a challenge that is a research 
funding priority for the National Pork Board—but so far 
there has been no success. 
With a Pork Board grant, Dr. Zuckermann developed a 
cell line in three years with just three attempts.
“We were able to make a cell line that is robust and 
grows the [PRRS] virus,” he acknowledges, but he is very 
protective of his discovery. 
“I’m the only one who touches the cell line. It’s like 
growing orchids, almost. Very difficult. It has to be free of 
impurities, pathogens—everything. We don’t even put in 
an antibiotic.”
In January he applied for a patent for “ZMAC-1,” the 
cell line he developed from a third-generation pig alveolar 
macrophage cell line. The ZMAC-1 line was started on 
May 6, 2006, with a few thousand cells and has since pro-
duced over a billion cells.
“I’m very confident that it will be robust enough to use 
for commercial purposes,” he says.
Dr. Zuckermann believes he has also mastered the 
second key need for developing vaccine: finding a strain 
of the virus that will elicit a broadly protective immune 
response.
“The beauty of science is if you look you’ll find. There is 
so much to discover. There is no end. That’s what is excit-













Dr . Federico Zuckermann holds a flask of ZMAC-1 . “It’s like 
growing orchids,” he says of the delicate cell line he developed 
to grow the PRRS virus . Dr . Gabriela Calzada-Nova is a member 
of his lab .
“I’m the only 
one who 
touches the 
cell line . It’s 
like growing 
orchids, almost . 
Very difficult . It 




continued on page 2
Technological Power 
A partnership with iCyt Mission Technology, Inc., a startup company located in the 
University of Illinois Research Park, has been a major boon to Dr. Zuckermann’s 
research. Through a collaborative agreement, a new ReflectionTM cell sorter, which 
offers multiple highly automated parallel sorting modules, was acquired and will be 
located in the Pathobiology Department for continued collaboration with iCyt and 
for the benefit of the research community at the University of Illinois. Dr. Zucker-
mann’s studies give iCyt engineers a very challenging real-world research application 
to help them validate the equipment and perfect the software.
Observing that “the PRRS virus knocks out the pig’s innate immune system” and, 
as a result, cells from PRRS virus-infected pigs become severely impaired in their 
ability to produce interferon alpha, Dr. Zuckermann decided to focus his efforts 
on plasmacytoid dendritic cells (PDCs), a cell population that produces copious 
amounts of interferon alpha and provides the 
body’s initial protective response to a virus. 
One obstacle to studying PDCs is isolating 
them: this cell type accounts for only one-
half of one percent of the pig blood in which 
they are found. With iCyt’s ReflectionTM, this 
infrequent cell population PDCs can be puri-
fied into a sample that is more than 90 percent 
PDCs with greater than 98% efficiency in a 
few hours. 
“The power of the new iCyt machine is 
that it is inside a biosafety cabinet,” says Dr. 
Zuckermann. “PRRS is a biosecurity level II 
agent. The ReflectionTM provides a sterile and 
safe environment, with a built-in laminar flow 
hood. And it can do three times the volume of 
the cell sorters on campus.” 
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White Paper Identifies 
Needs in PRRS 
Vaccine Research
Porcine Reproductive and Respiratory Syndrome 
(PRRS) is the most significant disease problem facing 
the swine industry worldwide. In the United States 
alone, PRRS is estimated to have an economic impact 
between $560 million and $762 million annually on 
pork producers. Yet nearly 20 years after PRRS was 
first identified, there has been little success in devel-
oping economical and effective control strategies for 
this highly variable viral disease.
On June 1 and 2, 2007, researchers at the College 
of Veterinary Medicine convened a group of 22 
national experts in PRRS, virology, immunology, and 
vaccinology to discuss the state of current knowledge 
about PRRS vaccination. The group included clini-
cal veterinarians, academic researchers, and vaccine 
industry scientists. 
The resulting white paper represents a significant 
advance in achieving scientific consensus on the 
knowledge gaps that must be addressed in order to 
produce successful vaccination strategies to control 
the impact of PRRS. If future research proceeds along 
suggested pathways, the group agreed that effective 
vaccine strategies could reach the market within the 
next 5 to 10 years.
Key areas for future research include identifying 
the mechanisms by which the PRRS virus causes 
disease and the components of the virus that play a 
role in inducing protective immunity.
Copies of the white paper are available on the 
College Web site or by contacting the Department of 
Pathobiology at 217/333-2449. 
PRRs, continued
A ReflectionTM cell sorter for use by 











 Dr. Zuckermann is one of five pathobiology researchers engaged in an 
integrated PRRS research effort spanning the molecular biology of the 
virus, virus-host interactions, and disease epidemiology in swine herds.
 Dr. Dongwan Yoo uses full-length infectious cDNA clones and “reverse 
genetics” to study the PRRS virus at the molecular level. 
 Dr. William Laegreid uses an eco-epidemiologic approach that includes 
state-of-the-art molecular genomics and population-based studies to 
examine factors affecting the PRRS virus. 
 Dr. Tony Goldberg looks at how the virus evolves within animals and on 
farms, and how viral evolution interacts with host immunity to influence 
the course and severity of disease in pigs. 
 Dr. Larry Firkins is concerned with best management practices on swine 
farms and the economic impact of PRRS on Illinois pork producers. 
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Asthma: cloned Pigs offer clues 
Using cloned pigs as a model, Dr. Federico Zuckermann has found 
evidence for the theory that environment plays an important role in an 
individual’s susceptibility to asthma.
Asthma is on the rise in industrialized nations. This chronic allergic 
disease, in which the immune system overreacts and causes acute respi-
ratory symptoms, afflicts about 20 
million Americans and kills about 
4,000 each year.
In an experiment done in col-
laboration with Dr. Larry Schook, 
animal sciences, Dr. Zuckerman 
evaluated the variation in cloned 
pigs’ immune response compared 
with pigs that were not genetically 
identical. Not surprisingly there 
was less variation in the cloned 
pigs.
But further experiments 
revealed that not all cloned pigs 
are born equal. A group from one 
sow exhibited a different immune 
response, even though they were genetically identical to the pigs from 
another sow. The only difference between litters was the “environment” 
of the sow’s uterus.
With the help of Dr. Murli Manohar, veterinary biosciences, Dr. 
Zuckermann developed a way to measure the pigs’ lung function to 
determine the degree of asthmatic response. The team was able to create 
a pig model for the disease, inducing asthma in more than 80 percent of 
pigs.
“If we could create a pig model that exhibits food allergy, that would 
be really useful,” says Dr. Zuckermann. “New foods could be scored to 
evaluate their potential for allergens.”
In the debate over whether environment or genetics contributes 
more to asthma and other allergic diseases, Dr. Zuckermann’s findings 
show that “environment” could relate to maternal environment or to the 
astoundingly broad world of gut flora.
“The potential impact of the microbial world on the function of the 
immune system is huge and vastly underappreciated,” asserts Dr. Zuck-
ermann. “The main interface is in the gut. There are more bacteria in the 
gut than there are cells in the body.”
Significantly, the environment of the gut can be altered, perhaps in 
ways that would reduce or eliminate allergic reactions.
“This is the ‘hope’ area,” he says. “The biology of the gut microflora 
may be controllable. The holistic physiological point of view is the way 
of the future to cure disease.”  
“The potential impact of the 
microbial world on the function of 
the immune system is huge . There 
are more bacteria in the gut than 
there are cells in the body .”
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By Lisa Xia
Osteosarcoma—the most common primary bone tumor 
in canines—is almost always fatal and causes excruciating 
pain as the cancer destroys the afflicted bone, typically in 
a limb.
Traditional therapy for osteosarcoma includes 
amputation of the affected limb, coupled with systemic 
chemotherapy. For dogs that are not good candidates for 
amputation due to pre-existing health problems such as 
obesity or osteoarthritis, definitive treatment options are 
limited. For these non-surgical patients, control of bone 
cancer pain is paramount and can be effectively achieved 
with palliative therapies combining radiation therapy to 
the affected bone with systemic chemotherapy. 
Many pet-owners find amputation an undesirable and 
aggressive surgical procedure. They would prefer to keep 
the leg on their pets, says Dr. Timothy Fan, an oncolo-
gist in the Department of Veterinary Clinical Medicine. 
Although patients treated with only radiation and che-
motherapy demonstrate significant pain alleviation, most 
dogs will eventually experience progressive bone cancer 
pain, ultimately resulting in humane euthanasia. That’s 
why finding new ways to manage bone cancer pain in 
conjunction with other therapies is important.
Dr. Fan is leading a study, along with Drs. Laura 
Garrett, Louis-Philippe de Lorimier, and Sarah Charney 
in the oncology section, to determine whether using 
pamidronate, a potent anti-resorptive agent, in conjunc-
tion with radiation and chemotherapy may effectively 
alleviate bone pain in dogs with osteosarcoma while 
maintaining or even surpassing the expected survival time 
associated with conventional treatment. 
novel Treatment Approach 
“I think cancer pain is a concept that is only beginning to 
be realized,” Dr. Fan says, adding that in the past, most 
studies have focused on controlling the cancer but not the 
pain associated with it. 
“What’s so novel about this study is that it is a study 
really looking at cancer pain management in the animal.”
Approximately 8,000 dogs in the U.S. are diagnosed 
with osteosarcoma each year. This cancer occurs almost 
exclusively in large and giant breed dogs, such as grey-
hounds, rottweilers, retriever breeds, Irish wolfhounds, and 
Newfoundlands. The median survival time for dogs treated 
with amputation and systemic chemotherapy is approxi-
mately 1 year, according to Dr. Fan.
The three-year randomized, placebo-controlled, double-
blinded study, funded by Morris Animal Foundation, is 
slated to enroll up to 50 dogs. All patients will receive 
standard dosages of radiation and chemotherapy to ensure 
ethical and humane treatment of dogs with osteosarcoma. 
Patients will be randomized to receive either pamidronate 
or a placebo saline solution. 
Pamidronate, an aminobisphosphonate, is currently 
used in human patients as a first-line therapy for metastatic 
carcinomas involving bone. It has shown effectiveness for 
reducing bone pain associated with tumor-induced patho-
logic bone resorption. 
Alleviating Bone cancer Pain May Prove 
an Alternative to Amputation









prefer to keep 
the leg on 
their pets .
Veterinary Report • Fall 2007 t
Dr . Timothy Fan (at right) works with Ian Sprandel in Dr . Fan’s laboratory in the Veterinary Teaching Hospital .
Focus on Quality of Life
Bone destruction, a significant contributor to bone 
pain, is caused by naturally occurring osteoclasts that—
overstimulated by cancer cells—essentially eat away the 
bone. Aminobisphosphonates directly inhibit osteoclastic 
activity—and therefore osteoclastic bone resorption—and 
in doing so, reduce malignant bone pain. In vitro, aminobis-
phosphonates have also shown direct anti-cancer proper-
ties, actually killing tumor cells at pharmacologic concen-
trations which are physiologically achievable, Dr. Fan says.
Throughout the course of the study, dog owners will 
work with researchers to subjectively evaluate the dogs’ 
level of activity and pain. The observations of pet owners 
will be coupled with researchers’ objective analyses of bone 
tumor density, changes in bone resorption markers, and a 
gait analysis test in which a computer assesses how the pet 
is walking.
If the study shows that dogs can live relatively pain-free 
without amputation for a duration of time that approaches 
the survival period offered by amputation (about 10 
months), the findings may change how pet owners opt to 
treat their dogs with osteosarcoma, says Dr. Fan. 
“It becomes an attractive alternative treatment option 
for osteosarcoma patients if we can achieve survival times 
closer to one year without amputation,” says Dr. Fan. 
canine-human cancer connection
While the focus of this study is to optimize the quality 
of life for cancer-afflicted dogs for as long as possible, the 
study also demonstrates the biologic similarity between 
human and canine osteosarcoma. The incidence of osteo-
sarcoma is significantly higher in dogs than in humans, 
and the fatality rate is much higher as well. Of the small 
percentage of people who develop osteosarcoma, up to 70 
percent will be cured, Dr. Fan said. 
In addition, osteosarcoma progresses much more 
quickly in dogs than in humans, exhibiting the effects of 
the disease or benefits of treatment within a year compared 
with about five years in human beings. 
Dr. Fan hopes that the similarities between canine and 
human osteosarcoma demonstrated in this study will also 
influence the way researchers look to dogs as a subject for 
later studies concerning human health and medicine.
“In future studies, as we evaluate novel cancer thera-
peutics in the pipeline of development, the dog should be 
considered an accurate comparative model for the study of 
osteosarcoma and other tumor types shared between dogs 
and people,” Dr. Fan says. 
“In future studies, as we evaluate 
novel cancer therapeutics in the 
pipeline of development, the dog 
should be considered an accurate 
comparative model for the study 
of osteosarcoma and other tumor 
types shared between dogs and 
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By Lisa Xia
In August, Dr. Victor “Ted” Valli, pathobiology, brought 
thirteen of North America’s best veterinary pathologists to 
Urbana to examine 300 tissue samples of canine lymphoma 
collected from across the United States. They sought to 
identify a spectrum of diseases in lymphoma, a cancer that 
has traditionally been treated as a single disease in dogs. 
Through this meeting and another to be held later this 
year—both funded in part by grants from the American 
Kennel Club and the American College of Veterinary 
Pathologists—25 international experts will eventually 
examine the lymphoma samples. 
The goal: to set international standards for diagnos-
ing canine lymphoma and change the way treatment is administered to 
afflicted dogs. 
Tailored Treatment
Lymphoma, a type of cancer that affects the lymph nodes, liver, and 
spleen and is among the most common types of cancer affecting dogs, is 
usually treated with a standard dosage of chemotherapy. 
“The problem is that in veterinary oncology, the disease has been 
treated as generic and in a generic manner,” Dr. Valli says. “But some 
lymphomas are slow-growing and others are violently progressive. The 
high-grade tumors tend to be undertreated, and for the low-grade 
tumors, dogs suffer the destruction of normal tissue. Our work has 
shown that lymphomas in the dog have the same level of variability as 
they do in people.” 
Lymphocytes come in two major families that are known as B-cells 
(because they were first identified as an entity in the lymphoid “Bursa” 
of birds) and T-cells 
(because they receive 
their early training in 
the thymus gland). In 
humans, there are 16 
different disease sub-
types of lymphoma 
for each of the B-cell 
and T-cell types, 




genetic make-up in 
humans and dogs, as 
well as the cancers 
that occur in both 
species, are so similar, 
Dr. Valli is confident 
that the specialists will be able 
to identify similar sub-types of 
canine lymphomas with a high 
degree of accuracy. 
The identification of these 
16 disease subtypes for B- and 
T-cells was in large part due to 
a change, in 1993, in the World 
Health Organization’s method of 
classifying the different variet-
ies of human cancers. Medical 
doctors prescribe treatment spe-
cific to a particular disease. The 
August conference tested the viability of the WHO classification system 
for lymphomas in dogs.
If successful, the project will enable specialized cancer diagnoses so 
that dogs with different varieties of lymphoma can receive individual-
ized treatment. 
“The oncologists are limited in their treatment of lymphoma by 
the degree of specificity they get in the diagnosis,” Dr. Valli says. “If the 
diseases have this huge variability from very aggressive to very indolent, 
the disease should direct the treatment.”
Worldwide Access
Fifty slides of tissue samples have been digitized and posted in an online 
database with public access. The database was created in collaboration 
with Dr. Fred Dee of the College of Medicine at the University of Iowa. 
These cases include controls for the various stains that permit recogni-
tion of the B- and T-cell subtypes under a magnification of up to 400 
times. When the study is complete, consensus diagnoses 
will be added to the database to provide an easily accessible 
international standard for canine lymphoma identification. 
“Now this is neat because a pathologist anywhere can 
ask how his case compares to another one and bring up this 
database,” Dr. Valli says. 
As the treatments for the dogs change in accordance 
to the type of lymphoma identified, Dr. Valli will track 
how the variation in treatment will affect the dog’s survival 
and life quality. Eventually, Dr. Valli hopes to publish how 
treatment affected the outcomes for all animals involved in 
this study, which received additional funding from Idexx 
Laboratories, Fort Dodge Animal Health Products, Dr. 
Sally Lester, and a private veterinary pathology service.
For now, he is certain of the project’s success and its 
potential to instigate change.
“We feel that this will tremendously benefit dogs and 
their owners and improve our ability to understand these 
diseases,” he says.  
International experts Bring Who standards 
to canine Lymphoma Diagnoses
The second group to review the slide set included (from left) Dr . 
Jeff Caswell, Ontario Veterinary College, Guelph; Dr . E .J . Ehrhart, 
Colorado State University, Fort Collins; Dr . Dorothee Bienzle, 
Ontario Veterinary College, Guelph; Dr . Sally Lester, Central 
Laboratory for Veterinarians Ltd ., Langley, B .C .; and Dr . Ted 
Valli, University of Illinois, Urbana . Dr . Jose Ramos-Vara, Purdue 
University, West Lafayette, Ind ., was also part of this group . 
Canine lymph node .
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Three years ago, a team in the 
pathology and immunology 
department at the Washington 
University School of Medicine in 
St. Louis used knockout technol-
ogy to remove a transcription 
factor from laboratory mice. The 
team expected to see mice with 
immunological problems. Instead, 
what resulted from the experiment 
were healthy mice that were curi-
ously sterile.
By word of mouth through 
graduate students, slides of the 
abnormal sperm cells found 
their way under the microscope 
of Dr. Rex Hess, a specialist in 
male reproductive and stem cell 
biology at the College of Veterinary Medicine. The project, which has 
made significant advancements in the understanding of how stem cells 
in the testes divide and differentiate, has since been reported in a letter 
published in the journal Nature. The mice and the work are now fully 
under the direction of Dr. Hess, Dr. Marie-Claude Hoffman, and Dr. 
Paul Cooke in the Department of Veterinary Biosciences.
For Dr. Hess, there is a personal motivation that inspires his interest 
in stem cell research. He believes that stem cells have the potential to 
cure diseases such as multiple sclerosis, a disease that afflicts his wife.
Current stem cell controversy arises primarily from the use of embry-
onic stem cells. However, researchers have recently found evidence that 
stem cells may exist in nearly all adult organs. These adult stem cells are 
more specialized and organ-specific than are embryonic stem cells. 
Research suggests that only stem cells may create new organ cells, 
Dr. Hess said. For example, normal liver cells that die over time may be 
replaced only by stem cells, either from liver stem cells or from other 
stem cells that become differentiated.
Asymmetric cell Division
In the normal mouse testis, the control model for this project, a sper-
matogonial cell that reproduces—a process called mitosis—duplicates 
asymmetrically, forming one differentiated cell that would eventually 
become a sperm and one new stem cell. 
However, in mice that have had the transcription factor ERM (an 
Ets-related molecule; Etv-5) removed, only the first wave of spermato-
genesis, or sperm creation, occurs . 
Transcription factors are 
proteins that facilitate specific 
gene activity and work to increase 
synthesis of factors that regulate 
cell physiology, including mitosis 
and differentiation.
At puberty, when sperm 
production becomes important, 
all stem cells in ERM knockout 
mice differentiate and become 
sperm instead of asymmetrically 
dividing to replace themselves. 
With no stem cells left to create 
more sperm, these knockout mice 
become sterile within four to five 
weeks of birth.
Although earlier research indi-
cated that in normal mice, ERM 
started being expressed at puberty 
(when ERM knockout mice began showing abnormalities), Dr. Hess’s 
team has recently found that ERM is expressed as early as four days 
after birth, indicating that there are more factors affecting what signals 
cause stem cells to differentiate. 
Far-reaching Applications
Dr. Hess believes that this research has potentially far-reaching applica-
tions, including a better understanding of testicular cancer, creating 
male contraceptives, and treatment for sterility. For example, other 
research has shown that sterile mice that were implanted with cell cul-
tures of sperm stem cells regained their ability to reproduce.
Sperm stem cells are particularly interesting, said Dr. Hess, because 
they are very similar to the embryonic stem cells but do not carry the 
same risks associated with embryonic stem cells. Because they are so 
undifferentiated, embryonic stem cells transplanted to various organs in 
research studies have been shown to reproduce uncontrollably and cause 
cancer-like growth. 
A recently published study showed that certain bone marrow stem 
cells implanted into the testes of mice were able to differentiate into 
sperm cell lineages, given that the testicular environments were favor-
able. Dr. Hess believes there should be a similar application with sperm 
stem cells, although the impact could be greater given the sheer number 
of sperm that are produced. 
“For each heartbeat, a male produces 1300 sperm,” Dr. Hess said. 
“That’s what makes sperm stem cells so excellent to study.” 
Missing Transcription Factor Leads to 
Insights into stem cell Biology
Stem cells research in the Department of Biosciences holds potential for 
applications in furthering the understanding of testicular cancer and treating 
sterility . Drs . Rex Hess, Paul Cooke, and Marie-Claude Hoffman collaborate on 
this work .
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By Lisa Xia
In 1993, cryptosporidium-contaminated water infected more than 
400,000 people in Milwaukee. The infective oocysts of this protozoan 
parasite created the largest outbreak of waterborne disease in United 
States history, killing over 100 people and giving hundreds of thousands 
of others severe diarrhea. 
Although outbreaks of this large scale are rare, cryptosporidium 
remains one of the leading causes of water contamination in Ameri-
ca—a problem that Dr. Mark Kuhlenschmidt, professor in pathobiol-
ogy, is trying to control. 
Dr. Kuhlenschmidt is amid a three-year, USDA-funded study deter-
mining best management practices for farms and other animal facilities 
to contain runoff contaminated with cryptosporidium or rotavirus. 
His co-investigators are Dr. Prasanta Kalita, professor in hydrology in 
the Department of Agricultural and Biological Engineering, and Dr. 
Theresa Banet Kuhlenschmidt, research scientist, and Paul Davison, 
graduate student, both of the Department of Pathobiology.
Their hypothesis for the most efficient way to control this type of 
water pollution? A little spin on the traditional vegetative filter strip. 
Microbial Runoff
Since the passage of the EPA’s Clean Water Act in 1972, farms—among 
other facilities—have been mandated to control nutrient runoff. The 
two traditional mechanisms used for containing runoff are lagoons and 
vegetative filter strips, also called buffer strips, which are plots of land 









Dr . Theresa Banet Kuhlenschmidt confers with her research partner and husband, Dr . Mark Kuhlenschmidt .
the buffer strip can be overloaded 
with microbes to a failing point, 
and how long cryptosporidium 
must stay in a filter strip before it 
will die.
His studies have used Cryp-
tosporidium parvum, the cattle- and 
human-infecting strain commonly 
found on farms. Although C. 
parvum is not usually the strain 
responsible for most human 
disease outbreaks, such as those 
seen in swimming pools and water 
parks (10 of 14 North American 
outbreaks have been caused by 
C. hominis), each fall, C. parvum 
usually affects 10 percent to 20 
percent of campus dairy cattle, and 
occasionally veterinary students 
who care for the cattle fall ill. 
And, it takes very few oocysts to create an outbreak.
“It only takes 132 oocysts to infect you and me,” Dr. Kuhlenschmidt 
says. “A single infected calf can release 1011 oocysts. That’s enough 
oocysts to infect everybody in the U.S. and a few other countries, theo-
retically.”
economically efficient
Dr. Kuhlenschmidt estimates the cost of building and installing a filter 
strip into a medium-sized farm—like the southern Illinois farm that is 
part of their grant—falls between $250,000 and $500,000. Even so, he 
says, filter strips are probably the most economically efficient solution to 
the polluted runoff problem.
After doing his post-graduate studies on cell adhesion mechanisms, 
Dr. Kuhlenschmidt found opportunity to apply his knowledge to a new 
project that he cared deeply about—protecting the world’s water sup-
plies. He hopes that his work can reduce contamination in the water-
ways and prevent the need for additional government-issued statutes to 
contain microbial pollution that can threaten the existence of the small 
to medium-sized animal farms.
“It’s very interesting work because there’s probably nothing more 
valuable to me than protecting our food supply and particularly, our 
water supply,” Dr. Kuhlenschmidt says. “Ideally, our research will help 
provide safe water for people to drink while maintaining animal agricul-
ture.”  
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over which runoff is directed. The buffer strip, a combination of soil and 
vegetation (usually grass), reduces runoff flow which results in patho-
gens penetrating into the soil and binding to the vegetation roots and 
soil particles, effectively blocking them from entering the waterways.
“Buffer strips have been used for a long time, but there are almost no 
data showing that they work for pathogens like protozoan parasites or 
viruses,” Dr. Kuhlenschmidt says.
Although the EPA has never written any similar legislation to 
specifically control microbial runoff, they have recently revised the 
Clean Water Act to include the regulation of CAFOs (concentrated 
animal feed operations) in an effort to reduce the amount of agricultural 
animal wastes entering the nation’s waters. Dr. Kuhlenschmidt believes 
additional legal statutes may be created as concern grows over microbial 
contamination of our environment and water resources. 
“I think the Milwaukee outbreak alerted people to the potential for 
contamination in the waterways and the need to control environmental 
runoff,” he says. 
Following the outbreak, the USDA’s National Research Initiative 
began sponsoring research to examine whether buffer strips could also 
contain infectious agents.
A natural solution
And, so far, Dr. Kuhlenschmidt’s research indicates that buffer strips 
can be extremely effective in that role. In addition, because the strips are 
made wholly of natural components, the land can be used efficiently if 
grass grown in the strip can be fed to cattle. 
“A natural solution, such as a buffer strip, that stops overland trans-
port of microbial pathogens and can be harvested, would be the easiest, 
most natural, cost-effective way to solve this problem,” Dr. Kuhlen-
schmidt says. “It’s an alternative to mandating some other kind of large 
lagoon or treatment of the soil, or letting it lay fallow and not using it.”
This new study will apply Dr. Kuhlenschmidt’s past studies on adhe-
sion properties of rotaviruses and cryptosporidium in determining how 
these microbes bind to grass and soil components in a vegetative filter 
strip. By examining the samples taken by wells in the field, he and his 
team will determine what factors most affect the efficacy of a buffer strip 
and evaluate the overall effectiveness of the project.
Research will take place on three scales: in the lab, on two small 
University-owned plots, and on one or two mid-sized farms.
Older studies indicate that cryptosporidium oocysts most readily 
bind to the clay in soil, while rainfall and the land’s slope most impact 
the strip’s efficiency, Dr. Kuhlenschmidt says. For example, if the slope is 
too steep, the runoff passes over the buffer strip too quickly to contain 
the microbes. Questions he hopes to answer in this study involve what 
soil and vegetation types are best for containing the microbes, whether 
Top: Oocysts of Cryptosporidium 
parvum magnified 1,000 times .
Middle and bottom: A scale model of 
a filter strip used in research at the 
agricultural engineering building .






Dr. Herbert Whiteley, dean of the 
College, and Dr. Elysia Schaefer, 
equine surgery resident, were 
elected to leadership positions in 
the American Veterinary Medical 
Association in July. 
Dean Whiteley was elected 
to a six-year term representing 
veterinary medical research on the 
AVMA Council on Education.
Dr. Schaefer was elected to an 
unexpired term (ending in 2010) 
representing recent graduates 
on the Council on Veterinary 
Service. Dr. Schaefer had served 
as the president of the Student 
American Veterinary Medical 
Association (SAVMA) in 
2004-05.
The current SAVMA Execu-
tive Committee includes two 
Illinois veterinary students: 







Three graduate students from 
the laboratory of Dr. Humphrey 
Hung-Chang Yao, veterinary 
biosciences, were selected from 
more than 240 student competi-
tors to receive awards for research 
presented at the 40th Annual 
Meeting of the Society for the 
Study of Reproduction, held in 
San Antonio, Texas, in July.
Ivraym Barsoum won the 
trainee research award in the 
poster presentation category for 
“Ectopic activation of the hedge-
hog pathway induces appear-
ance of Leydig-like cells in fetal 
ovaries.”
Denise Archambeault placed 
second in the oral presentation 
category for “Inhibin beta a and 
hedgehog: a novel regulatory loop 
in fetal testis cord development.” 
Chia-Feng Liu placed fourth in 
the oral presentation category for 
“The role of beta-catenin in devel-
opment of the fetal ovary.” 
The Department of Vet-
erinary Biosciences is home to 
eight faculty members who are 
affiliated with the University of 
Illinois Reproductive Biology 
Training Program, which engages 
in a broad scope of research on 
female and male reproductive 
biology at the organism, tissue, 
cell, and molecular levels. 
The Society for the Study of 
Reproduction, founded at the 
University of Illinois in 1967, is 
the leading scientific society for 
reproductive biology in the world.
Ivraym Barsoum, Denise 
Archambeault, and Chia-Feng Liu in 




As biomedical research has 
expanded at the University of 
Illinois, so has the need for 
veterinary pathologists to support 
researchers.
$3 Million Grant 
Furthers study 
of Risk Factors 
for hot Flashes
With the help of a five-year, $3 
million grant from the National 
Institute on Aging, a professor at 
the University of Illinois College 
of Veterinary Medicine will begin 
to examine why obesity is associ-
ated with increased risk of hot 
flashes in mid-life women.
Earlier this year, Dr. Jodi 
Flaws, veterinary biosciences, 
found that obese women have 
lower levels of estrogen.
Her new study, entitled 
“Risk Factors for Hot Flashes 
in Mid-Life Women,” will test 
the hypothesis that obesity 
is associated with hot flashes 
through mechanisms that involve 
ovarian failure, altered sex steroid 
hormone levels, and selected 
genetic polymorphisms.
Dr. Flaws and her colleagues 
at Johns Hopkins University will 
recruit obese and non-obese peri-
menopausal women aged 45 to 
54 and will follow them for four 
years to determine whether dif-
ferences in hormones or genetics 















Dr . Jodi Flaws








It is a need that Dr. Susan 
Ball-Kell, section head for the 
Program in Comparative Pathol-
ogy of Laboratory Animals, is 
trying to fill.
The new program, nicknamed 
“LAPP” for lab animal pathology 
program, was launched by the 
Veterinary Diagnostic Laboratory 
last year to provide a tissue-sam-
ple analysis service to biomedical 
researchers at the University of 
Illinois.
Dr. Ball-Kell, a clinical associ-
ate professor, expects her program 
to grow. LAPP currently supports 
the University of Illinois cam-
puses in Springfield, Urbana, and 
Chicago. On the Urbana campus 
nearly three dozen departments 
use lab animals, according to Dr. 
Randall Peper, associate director 
of the Department of Animal 
Resources.
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Ga. Falendyz screened the samples Czekala had collected 
for antibodies to orthopoxviruses using an ELISA-based 
assay. She also extracted DNA from skin samples con-
taining suspicious lesions and tested them for orthopox 
genomic material using real-time PCR.
The two came face to face only twice: once in early 
August at the National Veterinary Student Symposium, 
held in Washington, D.C., and again in mid August in 
Urbana at the poster session. 
Despite the logistical challenges of international col-
laboration, Czekala and Falendyz took first place for their 
co-authored poster.
Czekala and Falendyz’s work was part of an ongoing 
monkeypox study at the University of Illinois Earth and 
Society Initiative. Monkeypox virus is a serious threat to 
human health in Africa, but very little is known about 
the virus or its natural host. Dr. Tom Gillespie, assistant 
professor of pathobiology, and Dr. Joanna Shisler, assistant 
professor of microbiology, served as mentors on the project. 
Dr. Gillespie sees the program’s value in its potential 
to expand student’s thinking about research: “Our work in 
Uganda challenges our mentees to think broadly. They are 
exposed to a new culture, a new set of problems, and given 
an opportunity to address these challenges head on within 
the context of research that builds on their specific training 
in veterinary medicine. It’s a very rewarding process.”
The Summer Training Program is run by the Center 
for Zoonoses Research and co-sponsored by Merck-
Merial, the National Institute of Health National Center 
for Research Resources, and the College of Veterinary 
Medicine. 
Projects from 2007 summer Training Program
 Effects of Exposure to the Herbicides Atrazine and s-Metolachlor on Ribeiroia 
ondatatrae Infections of Bullfrog (Rana catesbeiana) Tadpoles
 Ashley Elzerman, Class of 2009
 Mentor: Dr. Val Beasley
 Effects of Forest Fragmentation and Domestic Livestock Interaction on the 
Transmission of the Water-borne Microbes Giardia spp. and Cryptosporidium spp. 
Between Non-human Primates and Livestock in Kibale National Park, Uganda
 Annie Lo, Class of 2009
 Mentors: Dr. Tony Goldberg, Dr. Tom Gillespie
 Gastrointestinal Salmonella Diversity in Galapagos Marine Iguanas 
Emily Wheeler, Class of 2008
 Mentor: Dr. Roderick Mackie
 Identification of Clostridial Isolates Responsible for Suspected Botulism 
Outbreak in Horses 
Jennifer Reinhart, Class of 2010
 Dusty Sachen, Class of 2010
 Mentor: Dr. Brenda Wilson
 Molecular Phylogenetic Analysis of Candida albicans Isolates from Humans and 
Non-Migratory Wildlife in Central Illinois
 Lauren Wrobel, Class of 2009
 Mentor: Dr. Lois Hoyer
 Parasitic Infections of Non-human Primates in Fragmented and Undisturbed 
Forests in Western Uganda 
 Martha Low, Class of 2009
 Mentors: Dr. Tony Goldberg, Dr. Tom Gillespie
 Potential Monkeypox Reservoir in Uganda
 Anna Czekala, Class of 2009
 Elizabeth Falendysz, School of Veterinary Medicine, University of Wisconsin
 Mentors: Dr. Tom Gillespie, Dr. Joanna Shisler
 SodA as a Virulence Factor in Streptococcus equi and Streptococcus 
zooepidemicus Infections
 Lisa Lukas, Class of 2009
 Mentor: Dr. Carol Maddox
 The Virulence Role of Pseudomonas aeruginosa pyocyanin in Chronic 
Suppurative Otitis Media
 Elisabeth Peters, Class of 2009
 Mentor: Dr. Gee Lau 
summer Program, continued from back page
college Moves Ahead with 
center in chicago
The Illinois Board of Higher Education recently gave the College the 
OK to use the name the “University of Illinois Chicago Center for Vet-
erinary Medicine” for its new Chicago-based initiative.
This new center, located at 2242 West Harrison, in the medical 
district just south of the Loop, will initially offer small animal primary 
care services, engaging students in the clinical and management aspects 
of the practice. Ultimately this venture is expected to augment the 
specialty caseload at the Veterinary Teaching Hospital in Urbana and 
help the College attract faculty, recruit students from underrepresented 
groups, collaborate with biomedical researchers in Chicago, and connect 
with new donors.
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Excerpted from news releases by Diana Yates, 
Life Sciences Editor, in the News Bureau at the 
University of Illinois at Urbana-Champaign. The 
entire articles are available online.
hot Flashes: studies 
explore the Role 
of Genes, obesity, 
and Alcohol
More than 40 million women a year experi-
ence hot flashes: unpredictable, sometimes 
disruptive, periods of intense heat in the upper 
torso, neck, and face. Yet very little research 
has focused on the underlying causes of hot 
flashes.
Three recent studies explored the role of 
genes, obesity, and alcohol consumption in 
contributing to—or lessening—the inten-
sity and frequency of hot flashes in midlife 
women. The studies were part of a five-year 
research effort led by Dr. Jodi Flaws, veterinary 
biosciences, and colleagues at the University of 
Maryland, Mercy Medical Center in Balti-
more, and the School of Medicine at Johns 
Hopkins University. 
The paper published in Maturitas reported 
on a cross-sectional study involving 639 
women aged 45 to 54. The researchers looked 
at individual differ-
ences in the genes 
that code for various 
hormones. Their find-
ings confirmed those 
from an earlier study by 
the same team that there is 
evidence of a genetic basis for 
hot flashes. 
In another paper, published in the 
journal Climacteric, the researchers used 
the same data to analyze the link between 
obesity and hot flashes. The researchers 
found a significant link between obesity and 
higher levels of testosterone as well as lower 
total estradiol, estrone, progesterone and 
sex hormone binding globulin. The finding 
on estradiol was surprising because adipose 
tissue produces and stores estradiol, the major 
estrogen in humans. Most people had assumed 
that obese women would have higher circulat-
ing estrogen levels because of this, according to 
Dr. Flaws. 
A third analysis, published in the journal 
Fertility and Sterility, examined the influ-
ence of alcohol consumption on hot flashes 
in midlife women. Although an earlier study 
showed that moderate alcohol consumption 
actually reduced the severity of hot flashes by 
25 percent, this study failed to turn up any 
significant hormonal differences between the 




E. coli Bacteria Migrating 
Between Humans, 
Chimps in Ugandan Park
Dr. Tony Goldberg, pathobiology, has found 
that people employed in chimpanzee-focused 
research and tourism in Kibale National Park 
in western Uganda are exchanging gastro-
intestinal bacteria—specifically Escherichia 
coli—with local chimpanzee populations. And 
some of the E. coli strains migrating to chimps 
are resistant to antibiotics used by humans in 
Uganda.
Other studies have found bacterial 
exchanges between humans and non-human 
primates—particularly in areas where the 
animals are known to frequent garbage piles 
near human settlements. But this was the 
first study to document the exchange of E. 
coli between humans and chimps in a pro-
tected wildlife area. It was also the first to find 
antibiotic-resistant strains in chimpanzees in 
Africa.
“Antibiotic resistance has traditionally been 
associated with two factors: indiscriminate 
and over-prescription of antibiotics by physi-
cians in the developed world and the inclusion 
of antibiotics in animal feed in the developed 
world,” says Dr. Goldberg. The new findings 
show that over-the-counter sales of antibiot-
ics for human consumption can also have an 
impact on wildlife.
This study, which was funded by the 
Morris Animal Foundation, appeared in the 
April 2007 issue of Biological Conservation. 
The research team included researchers from 
Makerere University in Kampala, Uganda, and 
McGill University in Montreal.
More at www.news.uiuc.edu/
news/07/0222chimps.html
Discoveries in the news
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Researchers Find 
Gene That spurs 
Development of 
the epididymis
Human sperm cells travel up to 6 meters in 
their transit from testes to penis, and most of 
that journey occurs in the epididymis, a tightly 
coiled tube that primes the cells for their ulti-
mate task: fertilization. 
In a paper published in the Proceedings of 
the National Academy of Sciences, Dr. Hum-
phrey Hung-Chang Yao, veterinary biosci-
ences, reported discovery of a gene—and 
related mechanism—essential to the embry-
onic development of the epididymis.
Investigating an anomalous specimen 
noticed by graduate student Jessica Tomas-
zewski, Dr. Yao’s team discovered that inhibin 
beta A spurs activity in the cells that form 
the walls of epididymal tube. Further study 
showed that a lack of inhibin beta A led 
to stasis in these cells. Without it, the cells 
divided too slowly to adequately lengthen the 
tube.
This research adds to the evidence that 
while testosterone is the master switch that 
triggers the development of male reproductive 
structures, it doesn’t work alone, Dr. Yao says. 
“The identification of inhibin beta A in the 
development of the epididymis is important 
for understanding the basic biology of male 
sexual development,” says Dr. Yao. “But it also 
provides new insight into male infertility.”
Graduate students Avenel Joseph and 
Denise Archambeault contributed to this 
study. The work was supported in part by the 




osteosarcoma in cats 
and Dogs May Improve 
Palliative care 
A molecular pathway known to have a role in 
the progression of bone cancer in humans is 
also critical to the pathology of skeletal tumors 
in dogs and cats, according to research by Dr. 
Anne Barger, pathobiology, and Dr. Tim Fan, 
veterinary clinical medicine. Their work could 
lead to advances in the palliative care of com-
panion animals afflicted with osteosarcoma.
The research examined the homeostatic 
role of an enzyme, receptor activator of nuclear 
factor kappa-B (known as RANK), and two 
key modulators of its activity: RANK ligand 
(RANK-L) and osteoprotegrin (OPG). In 
health, RANK, RANK-L, and OPG together 
keep the continual process of bone growth and 
resorption in balance. 
The researchers are the first to verify that 
the expression of this protein, which worsens 
the effects of bone cancer in humans, also 
occurs in cats and dogs with skeletal tumors. 
Their study appeared in the Journal of Veteri-
nary Internal Medicine. 
Eventual therapeutic interventions may 
make use of OPG or other RANK-L inhibi-
tors to slow the process of bone destruction in 
skeletal tumors in cats and dogs. Although not 
a cure, this could reduce the pain and other 
complications associated with bone cancer. 
Such therapies have proven effective at reduc-
ing pathologic bone loss in human bone cancer 
patients.
“Owners often make decisions to eutha-
nize based on pain,” says Dr. Barger. “If we 
can lessen the pain associated with the tumor, 
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Funding
Beasley V., Nathan Cummings Foundation, 
$40,000, Envirovet 2006
Beasley V., World Wildlife Fund, $10,000, 
Envirovet 2006
Byron C., USDA/Animal Health & Disease, 
$19,195, Osteoclast Regulators RANKL and 
OPG in Equine Articular Cells
Byron J., Wayne D. & Josephine Spangler 
Funds, $5,960, Correlation of Disease 
Staging of Canine Blastomycosis and 
Prognosis in Treated Dogs
Clark-Price S., Companion Animal Memorial 
Funds, $6,000, The Effects of Intraoperative 
Application of Intraarticular Morphine 
on Total Cell Count, Cell Differential, and 
Protein Concentration of Synovial Fluid 
in Horses Undergoing Arthroscopy for 
Osteochondrosis.
Flaws J., NIH, $325,590, The Role of Aryl 
Hydrocarbon Receptor in the Ovary
Goldberg T., Illinois Department of Agriculture 
Cattle and Swine Disease Funds, $11,200, 
PRRS Virus Epidemiological Control through 
Whole Genome Viral Sequencing
Goldberg T., Lindbergh, $10,160, Enhancing 
the Compatibility of Marine Protected Areas 
and Sustainable Recreational Fisheries 
Goldberg T., University of Minnesota, $75,000, 
Viral Genetic Variation and Cross-Protective 
Immunity to PRRS Virus: An Integrated 
Experimental and Epidemiological 
Approach 
Goldberg T., USDA/Hatch, $13,245, PRRS Virus 
Epidemiological Control through Whole 
Genome Viral Sequencing
Hahn N., USDA/APHIS, $91,609, Markers for 
Transmission of Pseudorabies from Feral 
Swine
Ham K., Companion Animal Memorial Funds, 
$3,881, Validation and Intra-Operative 
Use of a Rapid Parathyroid Hormone 
Assay to Measure Parathyroid Hormone 
in Dogs with Naturally Occurring Primary 
Hyperparathyroidism
Hart K., Illinois Department of Agriculture 
Cattle and Swine Disease Funds, $25,000, 
The Effect of Non-Medicated Food 
on Ourdoor Nursery Pig Health and 
Performance
Haschek-Hock W., University of Iowa, $16,030, 
PCBs Metabolism Genotoxicity and Gene 
Expression In Vivo
Haschek-Hock W., USDA, $5,000, Evaluation of 
a Potential for In Vivo Toxicity of Pyrrocidene 
A in Mice
Johnson Y., USDA/Animal Health & Disease, 
$19,476, Transmission of Methicillin-
Resistant Staphylococci between Horses and 
Humans
Johnson Y., USDA/Hatch, $16,851, Enhancing 
Food Safety for Retail Meat and Poultry 
Products
Kitron U., University of California-Davis, 
$80,845, Measuring Entomological Risk for 
Dengue
Kitron U., Yale University School of Medicine, 
$97,339, Spatial Risk Model for Ixodes 
scapularis-borne Borrelia 
Kuhlenschmidt M., USDA/Animal Health 
& Disease, $19,500, Mechanism of 
Crytoposoridium parvum Sporozoite-Host 
Cell Invasion
Kuhlenschmidt M., USDA/CSREES, $400,000, 
Control of Cryptosporidium and Rotavirus 
Contamination in Agricultural Watersheds
Maddox C., USDA/Hatch, $21,784, Common 
Virulence Attributes of Lancefield Group C 
Streptococci
Miller G., American Association for the 
Advancement of Sciences, $84,559, AAAS 
Science & Technology Policy Fellowship
Morin D., Illinois Department of Agriculture 
Cattle and Swine Disease Funds, $17,200, 
Influence of Milking Frequency on 
Antibiotic Concentrations in the Milk of 
Dairy Cows Treated with an Intramammary 
Antibiotic
Sable H., National Institutes of Health (NIH), 
$89,806, Assessment of Psychostimulant 
Addiction Risk Following Developmental 
PCB Exposure
Schantz S., NIH, $307,344, PCBSs, PBDEs 
Hearing Loss & Attention/Impulsivity: 
Mechanistic Studies in Animals
Stewart A., American Quarter Horse, 
$32,495, Growth Factor Enhancement of 
Mesenchymal Stem Cell-Based Therapies to 
Promote Tendon Healing
Stewart A., Grayson Jockey, $9,300, Growth 
Factor Enhanced Progenitor Cells for 
Tendon Healing
Stewart A., USDA/Animal Health & Disease, 
$18,944, Co-treatment with Hylartin-V and 
Triamcinolone on Inflamed Chondrocytes
Stewart M., American Society for Bone & 
Mineral Research, $38,500, Assessment 
of ADAMTS Expression and Activity by 
Chondrocytes
Stewart M., Illinois Regenerative Medicine 
Institute, $250,000, Restoring Mesenchymal 
Cell Plasticity for Musculoskeletal Tissue 
Regeneration
Stewart M., USDA/Animal Health & Disease, 
$19,500, Phenotypic Suitability of 
Intrasynovial Stem Cells for Articular 
Cartilage Repair
Stewart M., USDA/Hatch, $23,000, ADMTS 
Aggrecanase Expression and Activity in 
Equine Osteoarthritis
Terio K., University of California-Davis, $12,096, 
Investigating Health Threats to Conserve 
Endangered African Wild Dogs
Urbasic A., Companion Animal Memorial 
Funds, $1,500, Investigation of Myxoma 
Virus as an Oncolytic Agent
Urbasic A., Wayne D. & Josephine Spangler 
Funds, $5,500, Investigation of Myxoma 
Virus as an Oncolytic Agent
Valli V., American Kennel Club Canine Health 
Foundation, $42,128, A Collaborative Study 
by Veterinary Oncologists, Pathologist and 
Diagnostic Laboratories to Enhance the 
Detection, Diagnosis and Treatment of 
Canine Lymphoma 
Yoo D., National Pork Board, $98,876, 
Development of Stable Cell Lines Permissive 
for PRRSV Replication & Production
Yoo D., Pfizer Animal Health, $116,546, PRRS 
Virus Interaction with CD 163
Zuckermann F., National Pork Board, $109,520, 
Immunogenicity and Potency of PRRS 
MLV Vaccines with and without IFN-Alpha 
Suppressing Capacity
Zuckermann F., University of Minnesota, 
$190,716, Integrated Control and 
Elimination of Porcine Reproductive and 
Respiratory Syndrome Virus (PPRSV) in the 
U.S.
Research Projects Funded Between April 1, 2006, and March 31, 2007
Veterinary Report • Fall 2007 h
Featured Faculty
By Marie Labak
Quite probably the only person at the College to have per-
formed solo at Lincoln Center, Dr. Thomas Graves brings 
tremendous creativity to his varied role as faculty member.
Now an associate professor and head of the Small 
Animal Medicine section in our Veterinary Teaching Hos-
pital, Dr. Graves had wanted to be a veterinarian since he 
was five years old. Instead of pursuing that dream initially, 
Dr. Graves studied piano performance at Arizona State and 
spent several years as a professional pianist in New York 
City. 
Fortunately, the man who is considered by some to be 
one of the top endocrine experts anywhere found his way 
to a veterinary career. He got involved in research at the 
Animal Medical Center and earned a veterinary degree at 
Cornell University. After completing an internship at Ohio 
State and an internal medicine residency at Michigan State, 
Dr. Graves entered a PhD program at the University of 
Rochester with support from an NIH grant. 
His doctoral work investigated calcium signaling, and 
he’s focused recent work on calcium signals that underlie 
insulin secretion mechanisms. 
Like his career path, Dr. Graves’ approach to research questions is unusual.
“I am not a typical scientist in any way,” he says. “I have tremendous math anxiety, and I can’t 
figure out how to set the clock on my microwave. I’m really more of a right-brained person.”
But right-brained creativity may be what makes Dr. Graves so prolific and his research so varied.
Dr. Graves is constantly thinking of new questions to pursue. “I’m always going off in differ-
ent directions,” he notes. “I prefer my research to be based on something that is a little new to me, 
something I don’t know everything about, and of course something that is relevant to and has fruit-
ful possibilities for helping my patients and teaching my students.”
His curiosity has led him and his students to seek out better ways to measure glomerular 
filtration rate in cats, treatments for renal secondary hyperparathyroidism in cats, and diagnostic 
methods for early detection of feline diabetes. 
Dr. Graves is currently involved in developing some innovative new treatments for diabetes, 
both for cats and for people.
Along with his own work on diabetes, Dr. Graves is also partnering with Dr. Kelly Swanson in 
Animal Sciences at Illinois to study effects of diet on the development of glucose intolerance and 
obesity in cats.
In collaboration with Dr. Marcella Ridgway and Dr. Julie Byron in the Department of Veteri-
nary Clinical Medicine, Dr. Graves is working on new ways to assess platelet function using fluo-
rescence microscopy, on novel diagnostic tests for adrenal gland disease using immunocytochem-
istry, and on mining the important clinical gems from the Veterinary Teaching Hospital’s uniquely 
large caseload of dogs with blastomycosis.
Dr. Graves is also returning to his early roots in feline hyperthyroidism research by working to 
elucidate the intracellular signaling pathways of the feline thyrotropin receptor.
The questions never stop, and Dr. Graves brings his inquisitive nature to his teaching as well. 
He teaches courses that span all four years of the veterinary curriculum, from first-year clinical 
orientation and physiology to fourth-year internal medicine clinical rotations. 
“I want to encourage my students to question things. I like people to keep in mind that much of 
what they know isn’t true.” 
Even though he may be internationally renowned for his research, passing on this scholarly 
skepticism to his students may be one of the more rewarding aspects of Dr. Graves’ work. 
“I used to feel that I was a clinician first and a scientist second, but now I feel I’m a teacher first, 
then a clinician, then a researcher,” he says. “I love teaching—any course they’ll let me teach, I’ll 
teach.” 
“I am not a 
typical scientist 




and I can’t 
figure out 
how to set the 
clock on my 
microwave . I’m 
really more of 
a right-brained 
person .”
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Suzanne Berry
Assistant Professor, Veterinary Biosciences
 BS, University of Illinois at Urbana-Champaign, 1995
 PhD, University of Wisconsin at Madison, 2001
Research Interests: Utilizing stem cells to repair damage and 
prevent disease progression in murine models for human 
muscular dystrophies.
Dr. Berry’s doctoral studies in human oncology focused on the role of DNA 
mismatch repair proteins in processing drugs used to radiosensitize cancer 
cells. Her postdoctoral research in Holland continued her research on DNA 
repair and cancer. Dr. Berry has spent the past 3 years at the University’s 
Urbana campus completing post-doctoral research, which entailed isolating 
stem cells from mice, characterizing them, and utilizing them to treat muscle 
disease in a murine model for Duchenne muscular dystrophy.
“I’m very happy to be at the College of Veterinary Medicine,” says Dr. Berry. 
“My colleagues here are excellent scientists, and have also proven to be 
friendly and gracious.”
Natalie Coffer 
Visiting Clinical Instructor, Veterinary Clinical Medicine
* BVetMed, Royal Veterinary College, University of London 
Research Interests: Internal medicine issues, parasitism, and 
herd health for goats, sheep, and beef and dairy cattle and 
equine medicine.
Dr. Coffer received her veterinary medical degree from the 
Royal Veterinary College in London, England, and completed an internship 
in Field Services, Theriogenology and Production at the University of Georgia 
and an internship at the Royal College of Veterinary Surgeons in London. 
She then completed a combined equine and farm animal residency in large 
animal internal medicine at the University of Tennessee. She enjoys working 
on medicine cases of all large animal species and has a particular interest in 
camelid and small ruminant medicine. 
Levent Dirikolu
Assistant Professor, Veterinary Biosciences
 DVM, Ankara University, Turkey, 1992
 MVSc, University of Kentucky, 1997
 PhD, University of Kentucky, 2001
Research Interests: Pharmacokinetics of highly orally 
bioavailable salt formulations of triazine-based antiprotozoal agents, includ-
ing diclazuril and toltrazuril sulfone for the treatment and prophylaxis of 
Equine Protozoal Myeloencephalitis in horses; development and validation 
of analytical methods for the detection and quantification of therapeutic 
agents administered to racehorses and interpretation of the pharmacological 
significance of these analytical results.
Dr. Dirikolu was involved in the development of the first FDA-approved 
therapeutic medications for the treatment and prophylaxis of Equine Pro-
tozoal Myeloencephalitis. For the past four years Dr. Dirikolu has worked at 
Tuskegee University in Alabama as an assistant professor in veterinary phar-
macology. While at Tuskegee he was honored with the Faculty Performance 
award, the Norden Distinguished Teacher of the Year award, and the Pfizer 
Animal Health Research Excellence Award. 
Marie-Claude Hofmann
Associate Professor, Veterinary Biosciences
 BS, University of Lausanne, Switzerland, 1977
 PhD, University of Lausanne, Switzerland, 1988
Research Interests: Unraveling the molecular mechanisms 
of self-renewal and differentiation of spermatogonial stem 
cells in the mouse, and the disruption of these mechanisms 
by toxicants.
Dr. Marie-Claude Hofmann earned a PhD degree in cell biology and com-
pleted a 2-year postdoctoral appointment in the Department of Pathology of 
the University of Zürich School of Medicine, where she studied the biology 
and genetics of testicular cancer. Subsequently, she moved to the Burnham 
Institute for Medical Research in La Jolla, Calif., and focused her studies on 
the molecular aspects of male germ cell development. In 1995 joined the 
faculty at the University of Dayton, teaching cell biology and cancer biology. 
She joined the College in 2006. 
Dr. Gee Lau
Assistant Professor, Pathobiology
 BS, University of Wisconsin-Madison. 1990
 MS, University of Wisconsin-Madison, 1992
 PhD, Purdue University, 1996
Research Interests: Functional genomics; virulence mecha-
nisms and immunology of bacterial pathogen Pseudomonas aeruginosa in 
acute and chronic lung diseases, especially in cystic fibrosis airways; mecha-
nisms of P. aeruginosa resistance to pulmonary innate immunity protein 
surfactant protein A (SP-A).
In 1996, Dr. Lau was accepted as a two-year postdoctoral research fellow 
at the Imperial College School of Medicine in London, England. He then 
completed a second postdoctoral research fellowship from 1998 to 2001 
at Harvard Medical School in Boston, Mass. Over the past four years he has 
worked as a researcher and assistant professor at the University of Cincinnati 
Medical Center’s Division of Pulmonary, Critical Care & Sleep Medicine.
“The reputation of the College of Veterinary Medicine is known worldwide. 
The large number of foreign students and scholars studying and contributing 
to the teaching and research enterprise here are testaments to the College’s 
culture of excellence,” says Dr. Lau. “It’s a privilege to be a member of the 
College and University of Illinois community.”
Mark Mitchell
Associate Professor, Veterinary Clinical Medicine
 BS, University of Illinois at Urbana-Champaign, 1990
 DVM, University of Illinois at Urbana-Champaign, 1992
 MS, University of Illinois at Urbana-Champaign, 1997
 PhD, Louisiana State University, 2001
Research Interests: Invertebrate, fish, amphibian, reptile, avian, and non-do-
mestic mammal medicine and surgery, as well as conservation medicine and 
clinical issues in non-domestic species.
After completing a master’s in clinical epidemiology Dr. Mitchell taught 
zoological medicine at Louisiana State University, where he also completed 
a PhD in wildlife epidemiology. Dr. Mitchell also served as the director of the 
Wildlife Hospital at Louisiana State University. In February he returned to 
Illinois as a member of the internal medicine faculty, with a focus on wildlife. 
Dr. Mitchell looks forward to mentoring future veterinary professionals, 
maintaining an active hand in clinical medicine, and researching aspects of 
conservation medicine and clinical issues in non-domestic species.
James Naughton
Visiting Clinical Assistant Professor, Veterinary Clinical 
Medicine
 DVM, Purdue University School of Veterinary Medicine, 
2002
 MS, University of Illinois at Urbana-Champaign
Research Interests: The use of MRI with a gadolinium con-
trast agent to image early arthritic changes in canine and equine articular 
cartilage which are not visible with conventional imaging methods.
Dr. Naughton completed a rotating internship position at Washington State 
University’s College of Veterinary Medicine in 2003. He then worked at a small 
Student Scholars Present Research
The 2007 Phi Zeta Research Day, held on April 13, provided an opportunity for 
undergraduate and graduate students, veterinary students, interns, and residents 
to improve their presentation skills while sharing the results of their research. 
Phi Zeta is the national veterinary honor society that promotes high scholarship, 
research, and ethical standards in veterinary medicine.
Awards were given to the three best presentations in clinical and basic 
research. 
 Arthroscopic Computed Tomographic and Radiographic Evaluation of Radio-
Ulnar Incongruence in Labrador Retrievers, Kahrma Wagner, Veterinary Clinical 
Medicine (VCM) (3rd place, clinical)
 Assessment of LDH Nanoparticles for Delivery of Peptides and Nucleic 
Acids to Cells, Louise Lee, VCM 
 Chondrogenic Capacity of Cells Isolated from Equine Synovial 
Fluid, Yu-Wen Chen, VCM
 Class 1 Integron Detection and Antibiotic Resistance in 
Salmonella Isolated from Swine Production Systems, 
Sangeeta Rao, Pathobiology (1st place, clinical)
 Cloning and Characterization of Equine Aggrecan, 
Evelyn Caporali, VCM
 Diagnosing Equine Carpal Bone Fractures from a 
Rapidly Prototyping Bimodel Created from CT Data, 
Juli Breslin-Strange, VCM
 Effect of Hyaluronic Acid and Triamcinolone on IL-1 
Treated Chondrocyte Opellets, Elysia Schaefer, VCM
 Effects of Methylprednisolone and Glucosamine on 
Equine Chondrocyte Proteoglycan Metabolism In 
Vitro, Britany Benson, VCM (3rd place, basic science)
 Evaluation of a Gadolinium MRI Contrast Agent in 
Articular Cartilage Degeneration and Surface Defects, 
Jim Naughton, VCM (2nd place, clinical)
 Intraoperative Measurement of Parathyroid Hormone with 
a Rapid Assay in Dogs with Naturally Occurring Primary 
Hyper-Parathyroidism, Kathleen Ham, VCM
 Investigating the Anti-Neoplastic Effects of Intravenous 
Zoledronate in Cats with Oral Squamous Cell Carcinoma, 
Jacki Wypij, VCM
 Manipulation of the Life Cycle of Toxoplasma Gondii, Haruno Sengoku, 
Pathobiology
 Proliferation of Adult Sertoli Cells in a Conditional Knockout Mouse Lacking 
the Gap Junctional Protein Connexin 43, Santhi Sridharan, Veterinary 
Biosciences (VB)
 Proximodistal Alignment of the Canine Patella: Radiographic Evaluation and 
Association with Medial and Lateral Patella Luxation in Dogs, Ayman Mostafa, 
VCM
 Risk Factors for Rate of Osteotomy Healing in Dogs Treated with Tibial Plateau 
Leveling Osteotomy, Tobin Eshelman, VCM
 The Role of Aromatase in Mediating Uterine Response to Decidualization, 
Amrita Das, VB (2nd place, basic science)
 Tendon-Derived Progenitor Cells Can Differentiate Along Multiple Lineages, 
Jennifer Barrett, VCM (1st place, basic science)
 The Transcription Factor ERM (Ets-Related Molecule) Is Necessary in 
Both Spermatogonial Stem Cells and Sertoli Cells for Spermatogenesis, 
Carla Morrow, VB 
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animal practice in Greenfield, Ind., 
until 2004. He has spent the past 
three years at the College complet-
ing a residency in imaging.
“The clinicians and staff at the 
College have been very pleasant to 
work with throughout my residency 
and I look forward to working with 





 DVM, Seoul 
National Univer-
sity, Seoul Korea, 
1974
 PhD, University of Ottawa, Ontario 
Canada, 1988
Research Interests: Arteriviruses, spe-
cifically porcine reproductive and 
respiratory syndrome (PRRS) virus, 
which belong to a unique group 
of animal viruses, called the family 
Arterividae in the order Nidovirales.
After completing a PhD in animal 
virology at the University of 
Ottawa in Ontario, Dr. Yoo went 
on to do postdoctoral research at 
the Veterinary Infectious Disease 
Organization at the Western College 
of Veterinary Medicine in Canada. In 
1995, he joined the virology faculty 
at the Ontario Veterinary College at 
the University of Guelph. There he 
began his work on the PRRS virus, 
which has become the major focus 
of his research. 
“I am very much looking forward to 
working together with the people 
here and witnessing the future 
growth of the College,” says Dr. Yoo. 
More “New Faces” 
coming soon:
 R. Avery Bennett
 Carrie Breaux






 Maureen McMichael 
Research: The Gift that 
changes Lives
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Advancement news
By Brenda Betts
Kelsey was “just” a mixed-breed dog, 90 pounds 
and tawny, but utterly devoted to her family: 
two kids and their parents, the father overseas 
in the military.
When Kelsey was diagnosed with bone 
cancer in her leg, her family was devastated. 
Then, for over a year, Kelsey came to the Vet-
erinary Teaching Hospital two or three times 
every month for treatments that controlled the 
cancer pain and improved her bone stability.
Her owners told us that as soon as their 
car turned down the road to the hospital and 
Kelsey realized where she was going, she would 
quiver with excitement. She loved visiting her 
second family here, and she always got an outpouring of love from our students and 
staff. 
Our oncologists were able to give Kelsey an extra year without pain to enjoy her 
family.
And Kelsey gave something in return. As a patient participating in a drug trial, 
Kelsey contributed to research that will help find better ways to care for patients 
with osteosarcoma.
If you are like me, you love to hear about animals whose lives were touched by 
the expert care of a veterinarian. But what makes the work done at our College truly 
transformative is the potential for new knowledge, developed here, to have an impact 
far beyond the patients seen in our hospital.
The research mission of the College reaches past the confines of the community, 
and even exceeds the influence of the hundreds of veterinary practitioners who are 
educated here.
Through research, our College is discovering how to improve diagnostics, cure 
diseases, and protect public health around the globe.
You may not be able to contribute to research in the way that Kelsey did, but 
there is a rewarding role that you can play.
As part of the Brilliant Futures campaign launched this year by the University of 
Illinois, our College is seeking donors whose vision extends along this global scale.
Here are a few of the giving opportunities available:
 An endowed chair in pathobiology to support infectious disease research 
that could find the key to controlling asthma and other immune system 
disorders.
 An endowed program in oncology that acquires a linear accelerator to assist 
cancer care and discovery.
 An endowed professorship in small animal emergency and critical care to 
support faculty who will conduct research and mentor specialists in this area.
By supporting programs such as these, you can make a lasting impact on the lives 
of an untold number of animals and people. 
To discuss areas of interest to you, please contact me at any time. You can reach 
me at advancement@cvm.uiuc.edu. 
Current Clinical Trials 
in the Veterinary 
Teaching Hospital
Full details at www.vetmed.illinois.edu/vth/
 Cranial Cruciate Ligament Disease in Labrador 
Retrievers 
 Double-blinded, Placebo-controlled Study of 
Drug to Treat Dogs with Atopic Dermatitis.
 The Effect of Body Condition on Postoperative 
Recovery in Dachshunds with Intervertebral Disc 
Disease Treated with Surgery and Aggressive 
Physical Rehabilitation 
 Evaluation of the Effects of Deramaxx® and 
Rehabilitation on Hind Limb Function in Lame 
Juvenile Dogs with Canine Hip Dysplasia 
 Evaluation of a Novel Anticancer Agent in Dogs 
with Neoplasia
 Fructosamine Levels in Dogs with 
Hyperadrenocorticism Before and After 
Treatment
 Intra-operative Parathyroid Hormone Assay 
in Dogs with Naturally Occurring Primary 
Hyperparathyroidism
 Staging of Blastomycosis to Provide Prognostic 
Information
 Treatment for Canine Appendicular 
Osteosarcoma with a Novel Anticancer Agent 
 Use of a New Human Medication to Treat Renal 
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Alumnus Thankful for veterinary 
start to Medical career
Dr. Allan Graham and his wife Mary feel thankful for the good things 
that life has brought them. To express their gratitude, they recently 
decided to make a $500,000 gift to the College of Veterinary Medicine 
in support of the imaging program.
Growing up on a farm outside the town 
of Ursa, in western Illinois, Dr. Graham was 
very impressed with Dr. Charles Lantis, the 
veterinarian who cared for his family’s animals. 
Young Allan decided to pursue a veterinary 
career. 
After completing his undergraduate studies 
at the University of Illinois at Urbana-Cham-
paign, Dr. Graham enrolled in the College’s 
third veterinary class, the Class of 1954. 
He applied to the Class of 1953 but was not 
admitted because he was not a veteran. But he 
spent that year at the College even so: “I got a 
job working for Jesse Sampson, the physiology 
professor, in the old building,” he recalls. “I had 
to set up the physiology experiments to make sure they worked before 
the students tried them.”
By the time he reached his junior year, Dr. Graham had developed a 
keen interest in medicine—and the desire to become a medical doctor. 
One of his veterinary professors, Dr. L.E. St. Clair, encouraged him to 
follow his interest. The draft board, on the other hand, said not yet. He 
needed to finish the DVM program and complete two years of military 
service first. 
Eventually he went on to medical school at the University of Illinois 
at Chicago, an internship, residency, and fellowship, and a very success-
ful career as a thoracic and cardiovascular surgeon in Texas, 
where Dr. and Mrs. Graham have lived for the past 40 years. 
Dr. Graham excelled in both curricula, earning member-
ship in the Alpha Omega Alpha medical honorary society 
and the Phi Zeta veterinary honorary society.
Throughout his career, Dr. Graham continued to 
feel connected to his veterinary classmates. In 1994 the 
Grahams attended the fortieth reunion of the Class of 1954. 
“I saw the guys I went to school with,” he recalls. “They 
are terrific people. I got to see what’s happened at the 
College, including all the new buildings. It’s a fantastic 
program.”
After expressing an interest in giving back to the College 
and reviewing a number of opportunities to make a dif-
ference with a gift, the Grahams decided to support the 
burgeoning imaging program here. Their generosity will have an impact 
on patient care, teaching, and scholarship in the imaging and oncology 
programs at the Veterinary Teaching Hospital.
“We looked at various programs and decided that this is where we 
could most be of help,” says Dr. Graham.  
By Sarah Dowling
Veterinary pathologists and toxicologists play a crucial role in research, 
industry, and governmental settings, and the supply is not keeping up 
with the demand for these valuable professionals. In response to this 
shortage, the American College of Veterinary Pathologists and the 
Society of Toxicologic Pathology created the Coalition for Veterinary 
Pathologist Fellows. 
The coalition aims to support and create new training positions for 
students interested in entering this field. Through the coalition, the 
College received funding for a new anatomical pathology residency 
position from Glaxo SmithKline, the second-largest pharmaceutical 
company in the world, which has headquarters in the United Kingdom 
and operations based in the United States. Dr. Sandeep Akare was 
coalition channels Industry support for 
veterinary Pathology Training
continued on page 20
Dr . Matthew Wallig (left), coordinator of the anatomic pathology residency 
program, with Dr . Sandeep Akare .
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Faculty Directory
Names in bold indicate section 
leaders.
Department of Pathobiology
Daniel L. Rock, head
Research focus on infectious 
disease research: pathogen-host 








































Department of Veterinary 
Biosciences
Duncan C. Ferguson, head
Research focus on environmental 
toxicology and on reproductive 
























Department of Veterinary 
Clinical Medicine
David A. Williams, head
Research focus on endocrinology/
obesity/glucose homeostasis; 
orthopedic biology/stem cell 
research; zoological medicine.
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Arthur M. Siegel, assistant director
awarded this position, which 
continues through 2009. 
Dr. Akare, who has a PhD 
from the Indian Veterinary 
Research Institute in Izatnagar, 
India, and who conducted post-
doctoral research at the Arizona 
Cancer Centre at the University 
of Arizona for three years, has 
extensive experience in the field of 
cancer biology.
Dr. Matthew Wallig, coordi-
nator of the anatomic pathology 
residency program and adviser for 
the student chapter of the ACVP, 
says that Dr. Akare’s outstand-
ing experience and background 
made him highly qualified for the 
position. 
“Dr. Akare’s intense desire 
to do something more than in 
vitro culture work was what most 
impressed the College. He feels 
that it is important to take the 
knowledge garnered in the lab 
and translate that to changes 
in the whole animal,” says Dr. 
Wallig. “He sees veterinary 
pathology as the ‘ultimate tool’ in 
scientific research.”
Dr. Richard A. Peterson 
II, director of Molecular and 
Ultrastructural Pathology in the 
GlaxoSmithKline Molecular and 
Ultrastructural Pathology Group, 
will serve as the industry mentor 
to Dr. Akare. 
“I will provide insight into the 
role of veterinary pathology in 
the pharmaceutical industry and 
preclinical drug development, 
direct Dr. Akare’s externship 
experiences at GlaxoSmithKline, 
and provide guidance in his career 
development,” says Dr. Peterson. 
“With a proposed special faculty 
appointment, I also look forward 
to interaction with other trainees 
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seminars Focus on 
health Issues Bridging 
human-Animal Gap 
Stem cell therapy, cross-species infectious 
disease, and ecosystem health are topics 
addressed during the fall seminar series on 
translational biomedical research—inter-
disciplinary collaborations that “translate” 
fundamental research discoveries into practical 
biomedical applications to improve human 
and animal health and society.
The seminars, held on Mondays at noon on 
the College campus, are free and open to the 
public. Veterinarians can earn one hour free 
continuing education credit by attending. 
The lineup includes speakers from Ghent, 
Belgium; Saskatoon, Canada; Edinburgh, 
U.K.; Basel, Switzerland; and Valencia, Spain.
For the full schedule see http://www.cvm.
uiuc.edu/research/tbrseries.html. 
november
12 Mucosal vaccination and immunity, 
TBR seminar by J. A. Ellis, University of 
Saskatchewan, 
19 Strengthening health systems: the 
potential of cooperation between human 
and animal health, TBR seminar Jakob 
Zinsstag, Swiss Tropical Institute.
26 Emerging Diseases in Marine Mammals, 
Greg Bossart, Harbor Branch Oceanographic.
December 
6-7 Executive Veterinary Program, Urbana, Ill. A 
two-year certificate program.  
See http://www.evpillinois.org/
January 
20  Alumni Reception at the North American 
Veterinary Conference, Orlando. Fla.  
E-mail advancement@cvm.uiuc.edu.
February 
2 Horseman’s Clinic, Urbana, Ill. See  
www.vetmed.illinois.edu/ope/horseclinic/.
18 Alumni Reception at the Western 
Veterinary Conference, Las Vegas, Nev. 
E-mail advancement@cvm.uiuc.edu.
April 
5 Veterinary Medicine Open House, Urbana, 
Ill. See www.vetmed.illinois.edu/openhouse/.
12 Awards and Scholarships Celebration, 
Urbana, Ill. E-mail advancement@cvm.uiuc.
edu.
19 Doodle for Wildlife, Urbana, Ill. Contact the 
Advancement Office, 217/333-2762.
“Dr. Akare has solid teaching experience 
and experience with curriculum development, 
which further enhances his potential, not just 
as a future researcher in veterinary pathology 
but as an educator as well,” adds Dr. Wallig. 
For more College  
events listings, visit  
www.vetmed.illinois.edu









“All science nowadays is collaborative in nature,” notes Dr. 
Brenda Wilson, associate professor of microbiology and co-
director of the University of Illinois Center for Zoonoses 
Research. 
Given that observation, the College’s summer research 
training program for veterinary students, now in its fifth 
year, decided to foster more realistic laboratory and field-
work experiences. The students who participated in team-
based projects came out winners.
Dr. Wilson mentored second-year students Jennifer 
Reinhart and Dusty Sachen. 
“Their joint project gave them exposure to a ‘real-life’ 
scientific experience: planning experimental design, execut-
ing the laboratory experiments, interpreting the data, and 
reporting the data,” says Dr. Wilson.
Reinhart and Sachen collaborated on a study of 17 
Illinois horses that exhibited botulism-like signs, including 
flaccid paralysis. Bacterial isolates from necropsy, fecal, and 
environmental samples had been submitted to the College’s 
Veterinary Diagnostic Laboratory. The laboratory isolated 
Clostridium sp. but was unable to conclusively determine 
the presence of a toxin gene. The students’ goal was to more 
specifically identify the strains of Clostridium present in the 
samples and to isolate and identify the responsible toxin 
gene. 
Working together in the 
lab, the students amplified 
DNA segments using universal 
bacteria primers, then cloned 
and sequenced the DNA and 
compared it with an established 
database to identify three species 
of Clostridium.
Reinhart says the program 
expanded her idea of research, 
and she’d like to incorporate 
research in her future career. 
“It’s given me a taste of a different kind of lab work,” she 
notes. 
Reinhart and Sachen placed second in the scientific 
poster session that capped the summer research program. 
Collaboration meant something very different for 
third-year veterinary students Anna Czekala and Elizabeth 
Falendyz, who worked together despite being an ocean 
apart. 
In a study of transmission pathways for the monkeypox 
virus, Czekala spent the summer in Uganda collecting 
samples from dormice. Meanwhile, Falendyz, a veterinary 
student at the University of Wisconsin, was stationed at 
the Centers for Disease Control and Prevention in Atlanta, 
summer Program Teaches students 
essential Research skill: Teamwork
Illinois veterinary 
students Annie Lo and 
Anna Czekala pose 
with Alice and her 
children, members 
of a Ugandan family 
involved in the 
monkeypox study .
continued on page 11
